ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,064.00
-0.08%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36175
0.02%
Bitcoin
66,852.37
2.47%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ProMIS Neurosciences Inc (PMN)

  7. ProMIS Neurosciences Inc (PMN) News

PMN

ProMIS Neurosciences (PMN)

ProMIS Neurosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PMN
DateTimeSourceHeadlineSymbolCompany
05/14/20243:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMNProMIS Neurosciences Inc
05/14/20243:01PMGlobeNewswire Inc.ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
04/30/20246:00AMGlobeNewswire Inc.ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed AntibodiesNASDAQ:PMNProMIS Neurosciences Inc
04/09/20246:00AMGlobeNewswire Inc.ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALSNASDAQ:PMNProMIS Neurosciences Inc
04/04/20246:00AMGlobeNewswire Inc.ProMIS Neurosciences to Present in Upcoming Investor Conferences in April NASDAQ:PMNProMIS Neurosciences Inc
04/01/20243:15PMGlobeNewswire Inc.ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
03/11/20246:00AMGlobeNewswire Inc.ProMIS Neurosciences Strengthens Global Intellectual Property PortfolioNASDAQ:PMNProMIS Neurosciences Inc
02/22/20246:00AMGlobeNewswire Inc.ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:PMNProMIS Neurosciences Inc
01/22/20246:00AMGlobeNewswire Inc.ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein VaccineNASDAQ:PMNProMIS Neurosciences Inc
01/08/20246:00AMGlobeNewswire Inc.ProMIS Neurosciences Issues Letter to ShareholdersNASDAQ:PMNProMIS Neurosciences Inc
01/03/20246:00AMGlobeNewswire Inc.ProMIS Neurosciences, Inc. Announces Leadership TransitionNASDAQ:PMNProMIS Neurosciences Inc
12/20/20236:00AMGlobeNewswire Inc.ProMIS Neurosciences Announces Publication on Novel Target for ALSNASDAQ:PMNProMIS Neurosciences Inc
11/20/20236:00AMGlobeNewswire Inc.ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
11/14/20233:30PMGlobeNewswire Inc.ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
09/08/20236:00AMGlobeNewswire Inc.ProMIS Neurosciences Closes $20.4 Million Private Placement FinancingNASDAQ:PMNProMIS Neurosciences Inc
09/06/202311:18AMGlobeNewswire Inc.ProMIS Neurosciences to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PMNProMIS Neurosciences Inc
08/21/20233:12PMGlobeNewswire Inc.ProMIS Neurosciences Announces $20.4 Million Private Placement FinancingNASDAQ:PMNProMIS Neurosciences Inc
08/14/20234:33PMGlobeNewswire Inc.ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
07/17/20236:00AMGlobeNewswire Inc.ProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s PipelineNASDAQ:PMNProMIS Neurosciences Inc
07/14/20236:45AMGlobeNewswire Inc.ProMIS Announces Completion of ContinuanceNASDAQ:PMNProMIS Neurosciences Inc
07/10/20236:55AMGlobeNewswire Inc.ProMIS Neurosciences to Consolidate Trading on the Nasdaq ExchangeNASDAQ:PMNProMIS Neurosciences Inc
06/30/20237:00AMGlobeNewswire Inc.ProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions ApprovedNASDAQ:PMNProMIS Neurosciences Inc
06/29/20237:00AMGlobeNewswire Inc.CORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern TimeNASDAQ:PMNProMIS Neurosciences Inc
05/15/20234:00PMGlobeNewswire Inc.ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
05/08/20238:00AMGlobeNewswire Inc.ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
04/25/20234:00PMGlobeNewswire Inc.Data Presented at American Academy of Neurology Annual Meeting on Novel Vaccine Design for Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
04/24/20236:30AMGlobeNewswire Inc.ProMIS Neurosciences Presents Preclinical Data Highlighting Targeting of Toxic Misfolded Proteins in Alzheimer’s Disease and ALS at American Academy of Neurology Annual MeetingNASDAQ:PMNProMIS Neurosciences Inc
04/10/20236:30AMGlobeNewswire Inc.ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310NASDAQ:PMNProMIS Neurosciences Inc
03/29/20237:30AMGlobeNewswire Inc.Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023NASDAQ:PMNProMIS Neurosciences Inc
03/13/20238:00AMGlobeNewswire Inc.ProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual MeetingNASDAQ:PMNProMIS Neurosciences Inc
 Showing the most relevant articles for your search:NASDAQ:PMN

Your Recent History

COIN
MTRETH
MEGATRON
TSX
NSCB
NBI Sustainable Canadian...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved